HYDERABAD: A biotech startup company, incubated at the ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH), on Monday announced a human umbilical cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs) based therapy for Covid patients.

Transcell Oncologics has developed a proprietary cell-based platform technology, HEMATO UC-MSCs, with anti-cytokine storm properties, anti-inflammatory attributes and repairing abilities.

You have successfully cast your vote

Visit link:

Hyderabad varsity startup develops stem cell-based treatment for Covid - Times of India

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh